Psychometric Validation of a French Version of the PISQ-R and a New Questionnaire About Sexuality
2 other identifiers
observational
298
1 country
14
Brief Summary
The primary objective of this study is the psychometric validation of two questionnaires (PISQ-R and a new questionnaire on sexuality) as compared to a non specific questionnaire on female sexual function (FSFI).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2013
Longer than P75 for all trials
14 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 29, 2012
CompletedFirst Posted
Study publicly available on registry
July 3, 2012
CompletedStudy Start
First participant enrolled
January 18, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 20, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
April 20, 2017
CompletedNovember 19, 2025
July 1, 2017
4.3 years
June 29, 2012
November 17, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
PISQ-R questionnaire
12 months + 1 week
Secondary Outcomes (19)
PISQ-R questionnaire
baseline; day 0
PISQ-R questionnaire
6 months
PISQ-R questionnaire
12 months
New sexuality questionnaire
baseline; day 0
New sexuality questionnaire
6 months
- +14 more secondary outcomes
Study Arms (8)
Vaginal surgery +prothesis +sexuality
The 50 patients included in this group will have undergone vaginal surgery for pelvic organ prolapse with placement of a prothesis; these patients are sexually active.
Vaginal surgery +prothesis -sexuality
The 25 patients included in this group will have undergone vaginal surgery for pelvic organ prolapse with placement of a prothesis; these patients are NOT sexually active.
Vaginal surgery -prothesis + sexuality
The 50 patients included in this group will have undergone vaginal surgery for pelvic organ prolapse WITHOUT placement of a prothesis; these patients are sexually active.
Vaginal surgery -prothesis -sexuality
The 25 patients included in this group will have undergone vaginal surgery for pelvic organ prolapse WITHOUT placement of a prothesis; these patients are NOT sexually active.
Abdominal surgery +sexuality
The 50 patients included in this group will have undergone abdominal surgery for pelvic organ prolapse; these patients are sexually active.
Abdominal surgery -sexuality
The 25 patients included in this group will have undergone abdominal surgery for pelvic organ prolapse; these patients are NOT sexually active.
Urinary incontinence surgery + sexuality
The 50 patients included in this group will have surgery for urinary incontinence; these patients are sexually active.
Urinary incontinence surgery - sexuality
The 25 patients included in this group will have surgery for urinary incontinence; these patients are NOT sexually active.
Eligibility Criteria
Patients undergoing vaginal, abdominal or urinary incontinence surgery.
You may qualify if:
- Patient is not pregnant
- Patient can read and understand French
- The patient must have given her informed and signed consent
- The patient must be insured or beneficiary of a health insurance plan
- The patient has genital prolapse and/or urinary incontinence and/or anal incontinence, and have undergone surgery
You may not qualify if:
- The patient is under judicial protection
- The patient does not understand french
- Patient has vulvodynia
- Patient has painful bladder syndrome
- The patient has had chronic pelvic pain for longer than 6 months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (14)
APHP - Hôpital Antoine Beclere
Clamart, 92141, France
CHU de Clermont Ferrand - Hôpital Estaing
Clermont-Ferrand, 63003, France
G.C.S. Flandre Maritime - site Polyclinique de Grande-Synthe
Grande-Synthe, 59760, France
CH de la Rochelle
La Rochelle, 17019, France
APHP - Centre Hospitalier Universitaire de Bicêtre
Le Kremlin-Bicêtre, 94275, France
CHRU de Lille - Hôpital Jeanne de Flandre
Lille, 59037, France
CHU de Nîmes - Hôpital Universitaire Carémeau
Nîmes, 30029, France
Groupe Hospitalier Dioconesses - Site Reuilly
Paris, 75012, France
APHP - Hôpital Bichat - Claude Bernard
Paris, 75877, France
CHU de Poitiers
Poitiers, 86021, France
CH de la Région d'Annecy
Pringy, 74374, France
CH de Poissy - Saint-Germain-en-Laye
Saint-Germain-en-Laye, 78100, France
CHRU de Strasbourg - Hôpital de Hautepierre
Strasbourg, 67098, France
Hôpital Foch
Suresnes, 92151, France
Related Publications (1)
Fatton B, Hermieu JF, Lucot JP, Debodinance P, Cour F, Alonso S, de Tayrac R. French validation of the Pelvic Organ Prolapse/Incontinence Sexual Questionnaire-IUGA revised (PISQ-IR). Int Urogynecol J. 2021 Dec;32(12):3183-3198. doi: 10.1007/s00192-020-04625-6. Epub 2021 Jan 5.
PMID: 33399902RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Renaud de Tayrac, MD PhD
Centre Hospitalier Universitaire de Nîmes
- PRINCIPAL INVESTIGATOR
Brigitte Fatton, MD
Centre Hospitalier Universitaire de Nîmes
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 29, 2012
First Posted
July 3, 2012
Study Start
January 18, 2013
Primary Completion
April 20, 2017
Study Completion
April 20, 2017
Last Updated
November 19, 2025
Record last verified: 2017-07